The authors report a case of a patient who received alteplase for acute myo
cardial infarction and developed spontaneous subfascial hematoma without an
y evidence of direct trauma. Subfascial hematoma remains a rare and self-li
mited complication of thrombolytic therapy. The development of cutaneous ec
chymosis associated with a sudden fall in hemoglobin after the administrati
on of alteplase should strongly suggest the possibility of diffuse subfasci
al hematoma. Physicians should be aware of the possible association between
the use of alteplase and the development of subfascial hemorrhage.